Search

Scarlett Y. Goon

Supervisory Patent Examiner (ID: 11557, Phone: (571)270-5241 , Office: P/1600 )

Most Active Art Unit
1623
Art Unit(s)
1673, 1693, 1600, 1623, 4131
Total Applications
525
Issued Applications
185
Pending Applications
17
Abandoned Applications
329

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8892461 [patent_doc_number] => 20130165645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => '4-ISOPROPYL-6-METHOXYPHENYL GLUCITOL COMPOUND' [patent_app_type] => utility [patent_app_number] => 13/817666 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11217 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817666 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/817666
4-isopropyl-6-methoxyphenyl glucitol compound Aug 18, 2011 Issued
Array ( [id] => 7767878 [patent_doc_number] => 20120035118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'PHARMACEUTICAL COMBINATIONS' [patent_app_type] => utility [patent_app_number] => 13/196068 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6771 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035118.pdf [firstpage_image] =>[orig_patent_app_number] => 13196068 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/196068
Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antagonists Aug 1, 2011 Issued
Array ( [id] => 8232982 [patent_doc_number] => 08198420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Synthetic compounds useful as nodulation agents of leguminous plants and preparation processes thereof' [patent_app_type] => utility [patent_app_number] => 13/193505 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21279 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198420.pdf [firstpage_image] =>[orig_patent_app_number] => 13193505 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/193505
Synthetic compounds useful as nodulation agents of leguminous plants and preparation processes thereof Jul 27, 2011 Issued
Array ( [id] => 7744329 [patent_doc_number] => 20120022016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Compounds and methods for selectively targeting tumor-associated mucins' [patent_app_type] => utility [patent_app_number] => 13/135911 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11523 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022016.pdf [firstpage_image] =>[orig_patent_app_number] => 13135911 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/135911
Compounds and methods for selectively targeting tumor-associated mucins Jul 17, 2011 Issued
Array ( [id] => 9401741 [patent_doc_number] => 08691793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Modified macromolecules and associated methods of synthesis and use' [patent_app_type] => utility [patent_app_number] => 13/184401 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 71 [patent_no_of_words] => 38173 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13184401 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/184401
Modified macromolecules and associated methods of synthesis and use Jul 14, 2011 Issued
Array ( [id] => 7663643 [patent_doc_number] => 20110312912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'TREATMENT OF ARTHRITIS AND OTHER MUSCULOSKELETAL DISORDERS WITH CROSSLINKED HYALURONIC ACID' [patent_app_type] => utility [patent_app_number] => 13/165196 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9549 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312912.pdf [firstpage_image] =>[orig_patent_app_number] => 13165196 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/165196
Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid Jun 20, 2011 Issued
Array ( [id] => 7669511 [patent_doc_number] => 20110318780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'ENZYMATIC MODIFICATION OF GLYCOPEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/163473 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 33945 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13163473 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/163473
ENZYMATIC MODIFICATION OF GLYCOPEPTIDES Jun 16, 2011 Abandoned
Array ( [id] => 8140791 [patent_doc_number] => 20120094950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis' [patent_app_type] => utility [patent_app_number] => 13/162644 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14311 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094950.pdf [firstpage_image] =>[orig_patent_app_number] => 13162644 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/162644
Nutraceutical composition and methods for preventing or treating multiple sclerosis Jun 16, 2011 Issued
Array ( [id] => 8406442 [patent_doc_number] => 20120238510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'CRYSTALLINE FORM OF BENZYLBENZENE SGLT2 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/158724 [patent_app_country] => US [patent_app_date] => 2011-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16066 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13158724 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/158724
Crystalline form of benzylbenzene SGLT2 inhibitor Jun 12, 2011 Issued
Array ( [id] => 8406442 [patent_doc_number] => 20120238510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'CRYSTALLINE FORM OF BENZYLBENZENE SGLT2 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/158724 [patent_app_country] => US [patent_app_date] => 2011-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16066 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13158724 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/158724
Crystalline form of benzylbenzene SGLT2 inhibitor Jun 12, 2011 Issued
Array ( [id] => 8172303 [patent_doc_number] => 20120107867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'GLYCOPEGYLATED ERYTHROPOIETIN' [patent_app_type] => utility [patent_app_number] => 13/157575 [patent_app_country] => US [patent_app_date] => 2011-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 30296 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107867.pdf [firstpage_image] =>[orig_patent_app_number] => 13157575 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/157575
Glycopegylated erythropoietin Jun 9, 2011 Issued
Array ( [id] => 6014999 [patent_doc_number] => 20110223239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'SPERMICIDAL AND VIRUCIDAL PROPERTIES OF VARIOUS FORMS OF SOPHOROLIPIDS' [patent_app_type] => utility [patent_app_number] => 13/112122 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3699 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223239.pdf [firstpage_image] =>[orig_patent_app_number] => 13112122 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/112122
SPERMICIDAL AND VIRUCIDAL PROPERTIES OF VARIOUS FORMS OF SOPHOROLIPIDS May 19, 2011 Abandoned
Array ( [id] => 6088042 [patent_doc_number] => 20110217344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'SPERMICIDAL AND VIRUCIDAL PROPERTIES OF VARIOUS FORMS OF SOPHOROLIPIDS' [patent_app_type] => utility [patent_app_number] => 13/112144 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3700 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217344.pdf [firstpage_image] =>[orig_patent_app_number] => 13112144 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/112144
SPERMICIDAL AND VIRUCIDAL PROPERTIES OF VARIOUS FORMS OF SOPHOROLIPIDS May 19, 2011 Abandoned
Array ( [id] => 9581970 [patent_doc_number] => 08771973 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Methods for treating bleeding disorders using sulfated polysaccharides' [patent_app_type] => utility [patent_app_number] => 13/111746 [patent_app_country] => US [patent_app_date] => 2011-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16786 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13111746 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/111746
Methods for treating bleeding disorders using sulfated polysaccharides May 18, 2011 Issued
Array ( [id] => 6010142 [patent_doc_number] => 20110220539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'SYNTHESIS OF HIGH MOLECULAR WEIGHT IRON-SACCHARIDIC COMPLEXES' [patent_app_type] => utility [patent_app_number] => 13/108392 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18879 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20110220539.pdf [firstpage_image] =>[orig_patent_app_number] => 13108392 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/108392
Synthesis of high molecular weight iron-saccharidic complexes May 15, 2011 Issued
Array ( [id] => 7490179 [patent_doc_number] => 20110237530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'ANTI-XDR-TB DRUG, ANTI-MDR-TB DRUG, AND COMBINATION ANTI-TUBERCULOSIS DRUG' [patent_app_type] => utility [patent_app_number] => 13/075356 [patent_app_country] => US [patent_app_date] => 2011-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6399 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237530.pdf [firstpage_image] =>[orig_patent_app_number] => 13075356 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/075356
Anti-XDR-TB drug, anti-MDR-TB drug, and combination anti-tuberculosis drug Mar 29, 2011 Issued
Array ( [id] => 9882553 [patent_doc_number] => 08969319 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Agent for applying to mucosa and method for the production thereof' [patent_app_type] => utility [patent_app_number] => 13/070210 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14470 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13070210 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/070210
Agent for applying to mucosa and method for the production thereof Mar 22, 2011 Issued
Array ( [id] => 6102597 [patent_doc_number] => 20110166090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => '18-Membered Macrocycles and Analogs Thereof' [patent_app_type] => utility [patent_app_number] => 13/046375 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10239 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166090.pdf [firstpage_image] =>[orig_patent_app_number] => 13046375 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/046375
18-Membered Macrocycles and Analogs Thereof Mar 10, 2011 Abandoned
Array ( [id] => 8567174 [patent_doc_number] => 20120329745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'PLANT DISEASE CONTROLLING COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE' [patent_app_type] => utility [patent_app_number] => 13/579620 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4162 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579620 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/579620
PLANT DISEASE CONTROLLING COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE Mar 1, 2011 Abandoned
Array ( [id] => 6090399 [patent_doc_number] => 20110218159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2' [patent_app_type] => utility [patent_app_number] => 13/037490 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10665 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218159.pdf [firstpage_image] =>[orig_patent_app_number] => 13037490 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/037490
METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 Feb 28, 2011 Abandoned
Menu